Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Earlier diagnosis of intrahepatic cholestasis of pregnancy and adverse pregnancy outcomes

View through CrossRef
AbstractIntroductionWe aimed to determine whether pregnancies complicated by early diagnosis of cholestasis were associated with adverse maternal or neonatal outcomes.MethodsThis is a retrospective cohort study of singleton, non‐anomalous live gestations complicated by cholestasis from 2005 to 2019. We compared rates of adverse outcomes in pregnancies complicated by early (< 32‐week gestational age) versus late (≥ 32‐week gestational age) diagnosis of cholestasis. Our primary outcome of interest was rates of spontaneous preterm birth. Secondary outcomes included rates of iatrogenic preterm birth, meconium‐stained amniotic fluid, cesarean delivery for non‐reassuring fetal heart tracing, and neonatal intensive care unit admission.ResultsOf the 1247 pregnancies complicated by cholestasis, 241 (19.3%) had early diagnosis and 1006 (80.7%) had late diagnosis. After adjusting for confounders including peak total bile acid levels, earlier diagnosis of cholestasis remained associated with spontaneous preterm birth (OR 1.81; 95% CI 1.11–2.95), iatrogenic preterm birth (OR 1.59; 95% CI 1.12–2.67), and NICU admission (OR 1.43; 95% CI 1.04–1.95). A sub‐analysis to compare outcomes with severe cholestasis (peak total bile acids ≥ 40 µmol/L) showed that early diagnosis of severe cholestasis was also associated with spontaneous preterm labor (OR 2.41; 95% CI 1.34–4.34), iatrogenic preterm birth (OR 1.67; 95% CI 1.05–2.67), and NICU admission (OR 1.66; 95% CI 1.06–2.61).ConclusionFindings suggest that earlier diagnosis of cholestasis is associated with adverse outcomes and that this is not entirely driven by peak total bile acid levels.
Title: Earlier diagnosis of intrahepatic cholestasis of pregnancy and adverse pregnancy outcomes
Description:
AbstractIntroductionWe aimed to determine whether pregnancies complicated by early diagnosis of cholestasis were associated with adverse maternal or neonatal outcomes.
MethodsThis is a retrospective cohort study of singleton, non‐anomalous live gestations complicated by cholestasis from 2005 to 2019.
We compared rates of adverse outcomes in pregnancies complicated by early (< 32‐week gestational age) versus late (≥ 32‐week gestational age) diagnosis of cholestasis.
Our primary outcome of interest was rates of spontaneous preterm birth.
Secondary outcomes included rates of iatrogenic preterm birth, meconium‐stained amniotic fluid, cesarean delivery for non‐reassuring fetal heart tracing, and neonatal intensive care unit admission.
ResultsOf the 1247 pregnancies complicated by cholestasis, 241 (19.
3%) had early diagnosis and 1006 (80.
7%) had late diagnosis.
After adjusting for confounders including peak total bile acid levels, earlier diagnosis of cholestasis remained associated with spontaneous preterm birth (OR 1.
81; 95% CI 1.
11–2.
95), iatrogenic preterm birth (OR 1.
59; 95% CI 1.
12–2.
67), and NICU admission (OR 1.
43; 95% CI 1.
04–1.
95).
A sub‐analysis to compare outcomes with severe cholestasis (peak total bile acids ≥ 40 µmol/L) showed that early diagnosis of severe cholestasis was also associated with spontaneous preterm labor (OR 2.
41; 95% CI 1.
34–4.
34), iatrogenic preterm birth (OR 1.
67; 95% CI 1.
05–2.
67), and NICU admission (OR 1.
66; 95% CI 1.
06–2.
61).
ConclusionFindings suggest that earlier diagnosis of cholestasis is associated with adverse outcomes and that this is not entirely driven by peak total bile acid levels.

Related Results

Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
IntroductionLike other forms of embodiment, pregnancy has increasingly become subject to representation and interpretation via digital technologies. Pregnancy and the unborn entity...
Etiology and outcome of neonatal cholestasis: an experience in a tertiary center of Bangladesh
Etiology and outcome of neonatal cholestasis: an experience in a tertiary center of Bangladesh
AbstractBackgroundNeonatal cholestasis (NC) is a major cause of morbidity and mortality in young infants. This study examines the etiology of NC and its outcome during 2 years of f...
Nutrition in pregnancy
Nutrition in pregnancy
SUMMARY INTRODUCTION PHYSIOLOGICAL CHANGES DURING PREGNANCY Changes in body composition and weight gain Changes in blood composition Metabolic changes and adaptive responses K...
Aetiological factors in neonatal cholestasis
Aetiological factors in neonatal cholestasis
The aim of the study was to investigate factors of possible importance for the aetiology of neonatal cholestasis. The medical records of 85 cholestatic infants were retrospectively...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Parenteral Nutrition-Induced Cholestasis in Neonates: Where Does the Problem Lie?
Parenteral Nutrition-Induced Cholestasis in Neonates: Where Does the Problem Lie?
Background. Parenteral nutrition (PN) is an effective method of nourishing the neonate who is unable to receive full enteral feeds. Cholestasis can be a complication of PN and can ...
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract Introduction Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma Aims: The c‐erbB‐2 and c‐Met proto‐oncogenes are important for ...

Back to Top